Preventing Stroke Triggers in Children With Sickle Cell Anaemia in Mulago Hospital, Kampala (PREST ): a Randomized Control Trial
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT03666806
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2/3
- Enrolled
- 150 participants
- Sponsor
- Makerere University
- Registry
-
NCT03666806
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Uganda
- Registry status
- Unknown status
Technical summary
Registry record NCT03666806. Randomized; quadruple masking; primary purpose prevention. Start 2018-08-22 (actual); primary completion 2019-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Preventing Stroke Triggers in Children With Sickle Cell Anaemia in Mulago Hospital, Kampala (PREST ): a Randomized Control Trial
- Acronym
- PREST
- Condition
- Preventing Stroke in Sickle Cell Anaemia
- Intervention (Biological)
- Influenza vaccine
- Lead sponsor
- Makerere University
Record details
- Record id
cardio:ct-nct03666806- Content hash
6881a213a11f568a1ef92d20523a135db1c3615b10c0b260e85c921bc3aa6ec9